Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. (Q43833268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sebastian Mas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

Miguel Angel Hernández-Presa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

José Luis Martín-Ventura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Mónica Ortego

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Almudena Gómez-Hernández

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

José Tuñón

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Purificación Hernández-Vargas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

César Aparicio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Luis Ortega

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Fernando Vivanco

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Juan Gómez Gerique

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Cristina Díaz

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Gonzalo Hernández

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Egido

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

49-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerosis — An Inflammatory Disease

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Coronary plaque disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

In vivo and in vitro expression of a non-mammalian cyclooxygenase-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Role and regulation of cyclooxygenase-2 during inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Chemokines--chemotactic cytokines that mediate inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Interleukin-8 production by macrophages from atheromatous plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900547-0

10.1016/S0021-9150(01)00547-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11755922%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference